Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer
Status:
Completed
Trial end date:
2019-07-25
Target enrollment:
Participant gender:
Summary
A study of palbociclib in combination with letrozole as treatment of post-menopausal women
with hormone receptor-positive, her2-negative advanced breast cancer for whom letrozole
therapy is deemed appropriate.